USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Sep 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
FY 2017
Dec 31, 2017
|
FY 2016
Dec 31, 2016
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
|
—
|
10
|
10
|
14
|
10
|
10
|
7
|
13
|
18
|
12
|
| Avenova Spray |
—
|
—
|
9
+11.1%
share 88.7%
|
8
+2.0%
share 74.7%
|
8
+11.8%
share 53.1%
|
7
+14.6%
share 67.1%
|
6
-5.9%
share 60.1%
|
6
share 96.2%
|
—
|
—
|
—
|
| Avenova Direct |
—
|
—
|
—
|
—
|
—
|
5
+54.5%
share 50.0%
|
3
+230.0%
share 33.2%
|
1
share 15.2%
|
—
|
—
|
—
|
| Dermadoctor |
—
|
—
|
—
|
4
-14.5%
share 34.0%
|
4
+607.8%
share 28.8%
|
1
share 5.8%
|
—
|
—
|
—
|
—
|
—
|
| KN95 Masks |
—
|
—
|
—
|
—
|
—
|
—
|
3
share 31.4%
|
—
|
—
|
—
|
—
|
| Neutrophase |
—
|
—
|
—
|
1
+41.1%
share 13.2%
|
1
+165.2%
share 6.8%
|
0
-29.8%
share 3.6%
|
1
+150.7%
share 5.3%
|
0
share 3.2%
|
—
|
—
|
—
|
| Other Products |
—
|
—
|
1
-45.0%
share 11.0%
|
2
+22.7%
share 18.7%
|
2
share 11.1%
|
—
|
0
share 3.0%
|
—
|
—
|
—
|
—
|
| Product And Service Other |
—
|
—
|
0
-12.8%
share 0.3%
|
0
+30.0%
share 0.4%
|
0
+25.0%
share 0.2%
|
0
+33.3%
share 0.2%
|
0
-58.1%
share 0.2%
|
0
share 0.7%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Finance Services (SIC 6199)
- Listed as
- SDEV (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- West Palm Beach, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1389545
- Former names
- NovaBay Pharmaceuticals, Inc. (until Mar 23, 2026)
Other Finance Services companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.